NCT04076358

Brief Summary

The purpose of this project is to pilot test the effect of a tablet-based cognitive behavioral intervention (Tab-CBI) application on older adults' a) daily steps, b) fatigue level, c) self-efficacy, and d) quality of life at Week 1 (baseline), Week 4 (intervention completion), Week 6 (booster), Week 8 (follow-up #1), and Week 10 (follow-up #2) in a sample of 24 older adults. The investigators hypothesize that (a) individuals receiving Tab-CBI will have increased daily step counts, decreased fatigue level, greater perception of self-efficacy and quality of life than those receiving current RA fatigue management, and that (b) the effects will be sustained up through 4 weeks of follow-ups after the intervention completion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 23, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2020

Completed
Last Updated

November 4, 2020

Status Verified

November 1, 2020

Enrollment Period

10 months

First QC Date

August 30, 2019

Last Update Submit

November 2, 2020

Conditions

Keywords

arthritis, fatigue

Outcome Measures

Primary Outcomes (4)

  • daily steps

    daily step counts measured by an accelerometer

    24 hours

  • Fatigue severity

    self-reported fatigue severity measured by PROMIS Fatigue-8a

    past 1 week

  • perception of self-efficacy

    self-reported self-efficacy measured by PROMIS Short Form v1.0 Self-Efficacy for Managing Symptoms-8a

    24 hours

  • perceived quality of life

    self-reported perception of quality of life measured by WHOQOL

    past 2 weeks

Study Arms (2)

Tab-CBI

EXPERIMENTAL

The Tab-CBI group receives a tablet preloaded with the Tab-CBI application and an accelerometer. During the study period, the participants have four weekly educational sessions plus one booster session by the research assistant through a videoconferencing tool. The educational modules were developed based on the principles of cognitive behavioral therapy. The key elements of the modules include activity-pacing, adjustment of goal-setting to the current physical condition, setting priorities and structured planning of a simple walking activity and time off, and cognitive restructuring of activity demands (see attached, outline of education modules).

Behavioral: Tab-CBI

Usual Care

NO INTERVENTION

The usual care group receives Arthritis related fatigue management which are currently offered to the participants at the recruitment sites. Participant are also instructed to maintain usual activity during the study period. The control group participants also receive an accelerometer to count steps, but without a tablet.

Interventions

Tab-CBIBEHAVIORAL

Participants receive a tablet preloaded with Tab-CBI application and an accelerometer.

Tab-CBI

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>=50
  • has greater than minimal fatigue scoring ≥17 on the PROMIS Fatigue Short Form v1.0 Fatigue-8a.
  • self-reported diagnosis of Arthritis
  • having Wi-Fi at home.

You may not qualify if:

  • those who are currently engaging in regular exercise
  • non-ambulatory or having a condition that would limit the ability to walk (e.g., foot deformity, lower extremity joint surgery in past 6 months, stroke, severe chronic obstructive pulmonary disease, etc.)
  • overt delirium, dementia, or any conditions indicating deteriorating cognitive status as determined by the Mini-Cog

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts

Amherst, Massachusetts, 01003, United States

Location

MeSH Terms

Conditions

ArthritisFatigue

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jeungok Choi, PhD

    University of Massachusetts, Amherst

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study uses an experimental pre- and post-test repeated measures design. Those satisfying the inclusion and exclusion criteria are randomly assigned to the intervention (Tab-CBI, n=12) or comparison group (n=12).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 30, 2019

First Posted

September 3, 2019

Study Start

May 23, 2019

Primary Completion

March 15, 2020

Study Completion

March 18, 2020

Last Updated

November 4, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations